NewslettersHematopoiesis News Phase I Study of Selinexor in Combination with Salvage Chemotherapy in Adults with Relapsed or Refractory Acute Myeloid Leukemia By Jamie Kang - September 5, 2023 0 Investigators conducted a phase I, dose-escalation study of selinexor with mitoxantrone, etoposide, and cytarabine in 23 patients aged [Leukemia & Lymphoma] Abstract RELATED ARTICLES Dysregulation of Pancreatic β-Cell Autophagy and the Risk of Type 2... Newsletters June 14, 2024 A PDE3A-SLFN12 Molecular Glue Exhibits Significant Antitumor Activity in TKI-Resistant Gastrointestinal... Intestinal Cell News June 14, 2024 AMBRA1 Levels Predict Resistance to MAPK Inhibitors in Melanoma Dermal Cell News June 14, 2024